Quratis Company Description

Quratis Inc. engages in developing vaccines in South Korea.

It is involved in developing QTP101, a vaccine for tuberculosis; dendritic cell-based cell therapy for indications, including cancer, autoimmune, and infectious diseases; and peptide nucleic acid-based antimicrobial agents.

The company also offers drugs contract development and manufacturing services. Quratis Inc. was founded in 2016 and is based in Seoul, South Korea.

Quratis Inc.

Country	South Korea
Founded	2016
Industry	Biological Products, Except Diagnostic Substances

Contact Details

Address: Anam Building Seoul, 08375 South Korea
Phone	82 2 866 0604
Website	quratis.com

Stock Details

Ticker Symbol	348080
Exchange	KOSDAQ
Reporting Currency	KRW
SIC Code	2836